Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | PNLIP | P16233 | 2/20 | 0.41 |
| ▸ | UGT2B7 | P16662 | 5/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5675292 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL29394941 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL5680004 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL5676739 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL8743228 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL23868612 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL5675289 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL14356925 | 0.88 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL15494524 | 0.88 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL12234283 | 0.88 | ALDH1A1 (0.52) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0636126-B1 | PROCESS FOR PRODUCING SCLAREOLIDE | HENKEL KGAA (DE) | 1997-01-08 | — | — | EP | claimed |
| US-5525728-A | OXIDIZING AN AQUEOUS ALKALINE SOLUTION COMPRISING SCLAROL AND/OR ABIENOL, A RUTHENIUM CATALYST WITH AN OXIDIZING AGENT, SALT FORMATION WITH A BASE, THEN DESALTING WITH AN ACID | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1996-06-11 | — | — | US | claimed |
| EP-1773799-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY-ACTIVE COMPOUNDS | GIVAUDAN SA (CH) | 2010-09-08 | — | — | EP | disclosed |
| US-7683190-B2 | Process for the preparation of optically-active compounds | GIVAUDAN SA (CH) | 2010-03-23 | — | — | US | disclosed |
| US-20080064886-A1 | Process for the Preparation of Optically-Active Compounds | GIVAUDAN SA (CH) | 2008-03-13 | — | — | US | disclosed |
| US-7019152-B2 | Process for the optical resolution of a precursor of sclareolide | FIRMENICH SA (CH) | 2006-03-28 | — | — | US | disclosed |
| EP-1527034-B1 | A PROCESS FOR THE OPTICAL RESOLUTION OF A PRECURSOR OF SCLAREOLIDE | FIRMENICH & CIE (CH) | 2006-01-04 | — | — | EP | disclosed |
| US-20040192960-A1 | Process for the optical resolution of a precursor of sclareolide | FIRMENICH SA (CH) | 2004-09-30 | — | — | US | disclosed |
| EP-0636126-B1 | PROCESS FOR PRODUCING SCLAREOLIDE | HENKEL KGAA (DE) | 1997-01-08 | — | — | EP | disclosed |
| US-5525728-A | OXIDIZING AN AQUEOUS ALKALINE SOLUTION COMPRISING SCLAROL AND/OR ABIENOL, A RUTHENIUM CATALYST WITH AN OXIDIZING AGENT, SALT FORMATION WITH A BASE, THEN DESALTING WITH AN ACID | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1996-06-11 | — | — | US | disclosed |
| WO-1993021174-A1 | PROCESS FOR PRODUCING SCLAREOLIDE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1993-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064886-A1 | Process for the Preparation of Optically-Active Compounds | ADH1C, ADH1A, CYP2E1 | ALDH1A1 43/4885CYP3A4 65/4885CYP2C9 23/4885 |
| US-20040192960-A1 | Process for the optical resolution of a precursor of sclareolide | LSS, CYP51A1, DHCR7 | ALDH1A1 494/4885CYP3A4 450/4885CYP2C9 884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.